VOYA Investment Management
FBLG icon

VOYA Investment Management’s FibroBiologics FBLG Stock Holding History

VOYA Investment Management’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-503
Closed -$31.1K – 2816
2024
Q3 		$31.1K Buy
+503
New +$33.4K ﹤0.01% 2799

Other funds holding FBLG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAS
Optivise Advisory Services Franklin, Tennessee $197M AUM 26.07% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VOYA Investment Management's FBLG Position: Q4 2024 in Review

VOYA Investment Management sold out of FibroBiologics (FBLG) in Q4 2024, closing a stake of 503 shares — an estimated $31.1K sold.

VOYA Investment Management first reported a position in FBLG in Q3 2024 and held it in 1 quarter. The position peaked at $31.1K in Q3 2024. 63 funds tracked by Wall St. Rank hold FBLG as of Q4 2024.

  • VOYA Investment Management reported no remaining FibroBiologics position as of Q4 2024 after selling out during the quarter.
  • VOYA Investment Management sold 503 FibroBiologics shares in Q4 2024, an estimated $31.1K.
  • VOYA Investment Management first reported a position in FibroBiologics in Q3 2024 and held it in 1 quarter.
  • VOYA Investment Management's FibroBiologics position peaked at $31.1K in Q3 2024.
  • 63 funds tracked by Wall St. Rank held FibroBiologics as of Q4 2024.

Based on VOYA Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.